Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

19.67USD
26 Jun 2019
Change (% chg)

$0.11 (+0.56%)
Prev Close
$19.56
Open
$19.67
Day's High
$19.81
Day's Low
$19.60
Volume
7,718
Avg. Vol
183,597
52-wk High
$36.12
52-wk Low
$19.27

About

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies. The Company's therapeutic approach, which it refers to as Characterized Oral Desensitization Immunotherapy (CODIT), is... (more)

Overall

Beta: -0.16
Market Cap(Mil.): $1,222.35
Shares Outstanding(Mil.): 62.49
Dividend: --
Yield (%): --

Financials

  AIMT.OQ Industry Sector
P/E (TTM): -- 104.70 37.22
EPS (TTM): -3.62 -- --
ROI: -67.61 7.78 12.18
ROE: -73.63 8.33 17.03

Earnings vs. Estimates